German Nutrition Society) and National Institutes of Health (NIH) reference values
Desbonnet et al., 2015)
We are currently prescribing Zepbound only, and we are prescribing the brand-name medication only.
Novo Nordisk says the US FDA has approved a once daily pill version of Wegovy, described as the first approved pill of its kind The company said trials showed average weight loss of 16.6%, with about a third of roughly 1,300 participants losing 20% or more Novo Nordisk expects a US launch in early January 2026, with investors pushing shares up sharply after the announcement amid strong competition in the weight loss market US regulators have approved an oral version of Wegovy for chronic weight management, giving Novo Nordisk the first daily pill in this drug class cleared for obesity treatment, according to the company and US media reports
Both categories play crucial roles in managing type 2 diabetes by utilizing GLP-1s natural mechanisms, offering comprehensive benefits beyond simple glucose control, including weight management and cardiovascular protection
IVIM does not bill insurance directly and is a self-pay clinic, though it will run a prior authorization to check if your insurance company might reimburse you
